Hôpital Henri-Mondor — Créteil

Public research footprint of Hôpital Henri-Mondor, compiled from the ClinicalTrials.gov public registry.

402

Registered studies

119

Active

Recruiting now

199

Completed

Stopped or withdrawn

Most-studied conditions

HER2-(Ultra)Low Expressing Breast Cancer · Moderately to Severely Active Ulcerative Colitis · Non-Transfusion-dependent Alpha-Thalassemia · Non-Transfusion-dependent Beta-Thalassemia

Recently updated registry entries

NCT04770753 — A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With… (Active Not Recruiting)
NCT04770779 — A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With… (Active Not Recruiting)
NCT01343173 — Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hôpital Henri-Mondor?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.